114 related articles for article (PubMed ID: 38206083)
1. The different prognostic factors between metastatic and nonmetastatic disease of esophageal neuroendocrine carcinoma.
Zhong L; Pan Y; Han S; Qi Q; Liao H; Jiang Y; Shen J
Indian J Cancer; 2023 Oct; 60(4):512-520. PubMed ID: 38206083
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.
Dasari A; Mehta K; Byers LA; Sorbye H; Yao JC
Cancer; 2018 Feb; 124(4):807-815. PubMed ID: 29211313
[TBL] [Abstract][Full Text] [Related]
3. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.
Maru DM; Khurana H; Rashid A; Correa AM; Anandasabapathy S; Krishnan S; Komaki R; Ajani JA; Swisher SG; Hofstetter WL
Am J Surg Pathol; 2008 Sep; 32(9):1404-11. PubMed ID: 18670347
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis.
Mollica V; Massari F; Andrini E; Rosellini M; Marchetti A; Nuvola G; Tassinari E; Lamberti G; Campana D
Curr Oncol; 2022 Aug; 29(8):5846-5854. PubMed ID: 36005199
[TBL] [Abstract][Full Text] [Related]
5. The Role of Surgery in Treating Resectable Limited Disease of Esophageal Neuroendocrine Carcinoma.
Deng HY; Li G; Luo J; Li XR; Alai G; Lin YD
World J Surg; 2018 Aug; 42(8):2428-2436. PubMed ID: 29340724
[TBL] [Abstract][Full Text] [Related]
6. Pattern and risk factors for distant metastases in gastrointestinal neuroendocrine neoplasms: a population-based study.
Cai W; Tan Y; Ge W; Ding K; Hu H
Cancer Med; 2018 Jun; 7(6):2699-2709. PubMed ID: 29733523
[TBL] [Abstract][Full Text] [Related]
7. Survival According to Primary Tumor Location, Stage, and Treatment Patterns in Locoregional Gastroenteropancreatic High-grade Neuroendocrine Carcinomas.
Dasari A; Shen C; Devabhaktuni A; Nighot R; Sorbye H
Oncologist; 2022 Apr; 27(4):299-306. PubMed ID: 35380711
[TBL] [Abstract][Full Text] [Related]
8. Management of resectable esophageal and gastric (mixed adeno)neuroendocrine carcinoma: A nationwide cohort study.
van der Veen A; Seesing MFJ; Wijnhoven BPL; de Steur WO; van Berge Henegouwen MI; Rosman C; van Sandick JW; Mook S; Haj Mohammad N; Ruurda JP; Brosens LAA; van Hillegersberg R;
Eur J Surg Oncol; 2018 Dec; 44(12):1955-1962. PubMed ID: 30201419
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics, prognostic factors, and survival trends in esophageal neuroendocrine carcinomas: A population-based study.
Chen C; Hu H; Zheng Z; Yang Y; Chen W; Qiao X; Li P; Zhang S
Cancer Med; 2022 Dec; 11(24):4935-4945. PubMed ID: 35596661
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine carcinoma of the esophagus: clinical characteristics and prognostic evaluation of 49 cases with surgical resection.
Deng HY; Ni PZ; Wang YC; Wang WP; Chen LQ
J Thorac Dis; 2016 Jun; 8(6):1250-6. PubMed ID: 27293844
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of stage IV gastroenteropancreatic neuroendocrine carcinoma: Experience and outcomes in the United States.
Kerekes D; Frey A; Bakkila B; Kunstman JW; Khan SA
J Surg Oncol; 2023 Oct; 128(5):790-802. PubMed ID: 37435780
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of metastatic neuroendocrine carcinoma under first-line treatment with platinum etoposide with a focus on NEC score and Rb expression: Results from the multicentre RBNEC study of the Groupe d'Etude des Tumeurs Endocrines (GTE) and the ENDOCAN-RENATEN network.
Hadoux J; Kanaan C; Durand A; Hescot S; Hautefeuille V; Cadiot G; Tauveron I; Laboureau S; Do Cao C; Walter T; Petorin C; Blanchet O; Jannin A; Gu C; Faron M; Leteurtre E; Rousselet MC; Zakeyh JJ; Marchal A; Chatelain D; Beaulaton C; Hervieu V; Ducreux M; Scoazec JY; Baudin E
Eur J Cancer; 2021 Jul; 152():100-115. PubMed ID: 34090142
[TBL] [Abstract][Full Text] [Related]
13. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation?
Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
15. A Competing Risk Analysis Study of Prognosis in Patients with Esophageal Carcinoma 2006-2015 Using Data from the Surveillance, Epidemiology, and End Results (SEER) Database.
Yu Z; Yang J; Gao L; Huang Q; Zi H; Li X
Med Sci Monit; 2020 Jan; 26():e918686. PubMed ID: 31966000
[TBL] [Abstract][Full Text] [Related]
16. Treatment strategies for neuroendocrine carcinoma of the upper digestive tract.
Morita M; Taguchi K; Kagawa M; Nakanoko T; Uehara H; Sugiyama M; Ota M; Ikebe M; Sugimachi K; Esaki T; Toh Y
Int J Clin Oncol; 2020 May; 25(5):842-850. PubMed ID: 32036480
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological features and prognosis of patients with gastric neuroendocrine carcinoma from multiple centers in southern China].
Fang C; Wang W; Zhang Y; Feng X; Zeng Y; Li Y; Chen J; Chen Y; Zhou Z
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1230-1234. PubMed ID: 27928791
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a Novel Entity of G3 (High-grade Well-differentiated) Colorectal Neuroendocrine Tumors (NET) in the SEER Database.
Punekar SR; Kaakour D; Masri-Lavine L; Hajdu C; Newman E; Becker DJ
Am J Clin Oncol; 2020 Dec; 43(12):846-849. PubMed ID: 32910023
[TBL] [Abstract][Full Text] [Related]
19. Irinotecan plus cisplatin in patients with extensive-disease poorly differentiated neuroendocrine carcinoma of the esophagus.
Okuma HS; Iwasa S; Shoji H; Takashima A; Okita N; Honma Y; Kato K; Hamaguchi T; Yamada Y; Shimada Y
Anticancer Res; 2014 Sep; 34(9):5037-41. PubMed ID: 25202088
[TBL] [Abstract][Full Text] [Related]
20. Gallbladder neuroendocrine carcinoma diagnosis, treatment and prognosis based on the SEER database: A literature review.
Cai XC; Wu SD
World J Clin Cases; 2022 Aug; 10(23):8212-8223. PubMed ID: 36159526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
